You want to be long this big trend. This US company has strong growth potential ahead taking advantage of a growing market.

Global population is aging especially in US and Europe which is becoming a huge market for orthopedic implants.

Roughly 20% of European population is over 65 years old and the US will approach 20% by 2050. Replacement knee and hip surgeries peak at age 65 especially in the US when Medicare begins offering coverage for these surgeries. With an aging population the growth for orthopedic implants is only beginning.

Zimmer Biomet (ZBH) is a pure play on this industry.

The company earns about 90% of its revenues from orthopedic implants with an emphasis on orthopedic implant devices. It is the prefect play to take advantage of this industries growth.

Zimmer sells different types of replacement hip, knees and trauma products. They report these sales in five segments: knees, hips, SET (sports medicine, extremities, trauma, dental and spine, and other. Knees and hips generates 60% of their revenue today.

If you want to bet on this growth industry Zimmer (ZBH) is the right play for you.

Disclosure: I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. The information provided should NOT be considered advice. The topics discussed are risky and have the potential to lose a substantial amount. I am not an investment professional and therefore do not offer individual financial advice. Please do your own research before investing.

Need a Hive account? Sign up free here!